Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 7.040
- -0.100-1.40%
Close Feb 28 16:00 ET
- 7.040
- 0.0000.00%
Post 20:01 ET
181.48MMarket Cap-6.27P/E (TTM)
7.410High6.910Low44.80KVolume7.120Open7.140Pre Close316.96KTurnover0.34%Turnover Ratio640.00P/E (Static)25.78MShares22.00052wk High0.86P/B92.43MFloat Cap6.91052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM7.00%Amplitude6.910Historical Low7.075Avg Price1Lot Size
About Contineum Therapeutics Company
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
Company Profile
SymbolCTNM
Company NameContineum Therapeutics
Listing DateApr 5, 2024
Issue Price16.00
Founded2017
CEOMr. Carmine Stengone
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address3565 General Atomics Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-333-5280
Websitehttp://www.contineum-tx.com
Company Executives
- Name
- Position
- Salary
- Carmine Stengone
- Chief Executive Officer, President and Chairman of the Board
- 2.32M
- Stephen L. Huhn, M.D.
- Chief Medical Officer and Senior Vice President, Clinical Development
- --
- Peter T. Slover
- Chief Financial Officer and Principal Accounting Officer
- 1.03M
- Daniel S. Lorrain, PhD
- Chief Science Officer
- 1.79M
- Lori Lyons-Williams
- Independent Director
- 25.00K
- Dr. Todd C. Brady, M.D.,PhD
- Independent Director
- --
- Sarah Boyce
- Independent Director
- --
- Troy A. Ignelzi
- Independent Director
- --
- Olivia C. Ware, M.B.A.
- Independent Director
- --
- Evert B. Schimmelpennink
- Independent Director
- 23.82K